This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May 17;383(9930):1700-3.

doi: 10.1016/S0140-6736(14)60131-8. Epub 2014 Feb 24.

Treatment of Kawasaki disease with anti-TNF antibodies

Michael Levin¹, David Burgner²

Affiliations

Affiliations

¹ Section of Paediatrics, Faculty of Medicine, Imperial College London, London W2 1PG, UK. Electronic address: m.levin@imperial.ac.uk.
² Murdoch Childrens Research Institute, VIC, Australia; University of Melbourne, VIC, Australia; Monash Children's Hospital, VIC, Australia.

PMID: 24572998
DOI: 10.1016/S0140-6736(14)60131-8

Comment

Treatment of Kawasaki disease with anti-TNF antibodies

Michael Levin et al. Lancet. 2014.

. 2014 May 17;383(9930):1700-3.

doi: 10.1016/S0140-6736(14)60131-8. Epub 2014 Feb 24.

Authors

Michael Levin¹, David Burgner²

Affiliations

¹ Section of Paediatrics, Faculty of Medicine, Imperial College London, London W2 1PG, UK. Electronic address: m.levin@imperial.ac.uk.
² Murdoch Childrens Research Institute, VIC, Australia; University of Melbourne, VIC, Australia; Monash Children's Hospital, VIC, Australia.

PMID: 24572998
DOI: 10.1016/S0140-6736(14)60131-8

No abstract available

PubMed Disclaimer

Comment on

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC. Tremoulet AH, et al. Lancet. 2014 May 17;383(9930):1731-8. doi: 10.1016/S0140-6736(13)62298-9. Epub 2014 Feb 24. Lancet. 2014. PMID: 24572997 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information